MEDSIR IS AN INTERNATIONAL COMPANY THAT FOCUSES ON THE DESIGN, DEVELOPMENT, AND MANAGEMENT OF INDEPENDENT AND COLLABORATIVE RESEARCH IN ONCOLOGY. THE COMPANY’S MAIN GOAL IS TO CONTRIBUTE TO THE CLINICAL DEVELOPMENT OF INNOVATIVE TREATMENTS FOR CANCER PATIENTS.

SCIENCE, STRATEGY, AND PATIENT NEEDS, TOGETHER

OUR STORY

In 2012, breast cancer KOLs and experts in clinical development Dr. Javier Cortés, Dr. Antonio Llombart, Dr. Carlos Barrios, Dr. Sunil Verma and María Campos founded MEDSIR (Medica Scientia Innovation Research) with the goal to professionalize independent clinical research in oncology ensuring that the best ideas would be strategically developed and managed in an efficient way while complying with industry quality standards.

MEDSIR started as a company that encouraged researchers in breast and gynecological cancer to turn their brilliant research ideas into full clinical trials. By providing a strategic vision and a full support structure to manage investigator-initiated studies and helping to secure the funds needed, we have evolved into a company with a world-wide network of pantumoral oncology experts. MEDSIR has perfected a collaborative model for clinical development that brings together the benefits of a CRO-based company-sponsored paradigm and all the advantages of investigator driven clinical research.

DOWNLOAD COMPANY DOSSIER

OUR VISION AND MISSION

OUR VISION IS TO BECOME THE GO-TO COMPANY FOR GLOBAL CLINICAL RESEARCH WITH THE MOST IMPACT IN DEVELOPING NEW AND EFFECTIVE TREATMENTS IN ONCOLOGY. OUR MISSION IS TO TURN INDEPENDENT AND COLLABORATIVE CLINICAL RESEARCH INTO AN EFFICIENT AND STREAMLINED STRATEGY IN CLINICAL DEVELOPMENT.

CORE VALUES
OF OUR CLINICAL RESEARCH

SHARED-VALUE AS A FUNDAMENTAL WAY OF DOING BUSINESS WHILE ADDING VALUE TO SOCIETY.

Scientific Excellence

Through critical thinking and courage, we strive to develop the best possible clinical trials to fight cancer and improve patients’ lives. Patient welfare is the focal point of our actions. Quality is a condition of everything we do. We aspire to perfection to reach excellence.

Diversity

Diversity and inclusion are crucial both within our company and in our clinical trials.

Ethical Rigor &

Transparency

We uphold the highest ethical standards in everything we do. Integrity guides our actions, and accountability defines our behavior.

Transparency is essential to building trust and ensuring data integrity in clinical research. We foster openness, honesty, and mutual respect in all our interactions.

We believe that ethical rigor and transparency are inseparable pillars for creating value and advancing cancer research responsibly.

Transparency

Integrity, trust, and mutual respect are core to our everyday activities, both internally and with our partners.

Agility

We streamline clinical research to speed up

the journey from bench to bedside. Our flexible approach to clinical research knows no borders. Our focus is global.

MEDSIR IN NUMBERS

We have collaborated with over 40 pharmaceutical companies and biotechs.
We have designed and managed over 65 clinical studies, most of which are prospective international clinical trials.
We have a team of more than 120 highly qualified scientific professionals.
MEDSIR has joined forces with over 200 research sites in over 14 countries worldwide.
More than 100 clinical research ideas populate our intellectual pipeline

We have developed and managed clinical trials in many different solid tumors, including breast, lung, prostate and endometrial, and even in rare tumors such as thoracic or penile carcinomas. We have also developed and managed clinical research in diseases outside of oncology, such as COVID-19.

Our headquarters is in Barcelona (Spain), with a subsidiary in Cambridge. Massachusetts, USA.